The most recent investigation has established that UBE2S, an E2 ubiquitin-conjugating enzyme, plays a critical role in stabilizing β-linked proteins via K16-linked ubiquitination, which is known to trigger enhanced migration and invasion of tumor cells in the context of prostate cancer bone metastases and promote oncogenic activities. This evidence concerns the gene KRT16 and neoplasm.